GeneDx Holdings (WGS) Non-Current Deferred Tax Liability (2021 - 2026)

GeneDx Holdings (WGS) has reported Non-Current Deferred Tax Liability for 6 consecutive years, with $873000.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Non-Current Deferred Tax Liability rose 16.87% year-over-year to $873000.0 in Q2 2026; TTM through Jun 2026 was $873000.0, a 16.87% increase from a year earlier, with the FY2025 full-year figure at $757000.0, down 98.36% from the prior year.
• Non-Current Deferred Tax Liability was $873000.0 for Q2 2026 at GeneDx Holdings, down from $1.4 million in the prior quarter.
• Over five years, Non-Current Deferred Tax Liability peaked at $57.0 million in Q4 2022 and troughed at $747000.0 in Q2 2025.
• A 5-year average of $13.6 million and a median of $1.4 million in 2024 frame the typical range for Non-Current Deferred Tax Liability.
• Across the five-year window, Non-Current Deferred Tax Liability surged 1088.28% in 2022 and slumped 98.36% in 2025, its largest moves.
• Over 5 years, Non-Current Deferred Tax Liability stood at $57.0 million in 2022, then decreased by 0.88% to $56.5 million in 2023, then slipped by 18.04% to $46.3 million in 2024, then tumbled by 98.36% to $757000.0 in 2025, then gained by 15.32% to $873000.0 in 2026.
• The last three Non-Current Deferred Tax Liability figures came in at $873000.0 (Q2 2026), $1.4 million (Q1 2026), and $757000.0 (Q4 2025), per Business Quant data.